US 11142578
Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof
granted A61KA61K31/537A61K47/68033
Quick answer
US patent 11142578 (Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/537, A61K47/68033, A61K47/6849, A61K47/6857